Research on therapeutic clinical trials including immunotherapy in triple-negative breast cancer: a bibliometric analysis
BackgroundBreast cancer, particularly triple-negative (TNBC), is a leading malignancy with aggressive traits and high metastasis rates. Clinical trial is an important tool for optimizing therapeutic strategies in the evaluation of the safety and efficacy for TNBC. Our bibliometric study of TNBC clin...
Saved in:
Main Authors: | Qi Xu, Xiaoyu Feng, Siyuan Qin, Yu Hong, Rui Cui, Jia Liang, Zhuya Xiao, Yuan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1423924/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proteomic profiling identifies upregulation of aurora kinases causing resistance to taxane-type chemotherapy in triple negative breast cancer
by: Bohan Ning, et al.
Published: (2025-01-01) -
Tumor microenvironment and immunotherapy for triple-negative breast cancer
by: Zijie Guo, et al.
Published: (2024-12-01) -
Research trends of neoadjuvant therapy for breast cancer: A bibliometric analysis
by: Laiping Xie, et al.
Published: (2025-12-01) -
Platycodon grandiflorum-derived extracellular vesicles suppress triple-negative breast cancer growth by reversing the immunosuppressive tumor microenvironment and modulating the gut microbiota
by: Min Yang, et al.
Published: (2025-02-01) -
Classifications of triple-negative breast cancer: insights and current therapeutic approaches
by: Ziqi Chen, et al.
Published: (2025-02-01)